Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Proton pump inhibitors (PPIs) are currently the reference drugs for gastroesophageal reflux disease (GERD), but symptoms often recur after their withdrawal. Moreover, whether prokinetics or barrier drugs used alongside PPIs are more effective remains under debate.
Objectives: The aim of the study was to assess the efficacy of different therapeutic approaches to GERD treatment.
Material And Methods: We enrolled 211 grade A reflux esophagitis patients who consented to participate in this non-randomized, open-label trial. The study consisted of 6 sequentially administered medical treatments for GERD, lasting 2 months, with a 3-week washout period between each drug schedule: Group A: PPI (esomeprazole 40 mg/day before breakfast); Group B: mucosal protective drugs (a combination of hyaluronic acid, chondroitin sulfate and poloxamer 407, or a combination of hyaluronic acid, chondroitin sulfate and aluminum, 3 times daily after a meal); Group C: prokinetics (levosulpiride 25 mg or domperidone 10 mg, 3 times daily before a meal); Group D: barrier drug (alginate 3 times daily after a meal); Group E: PPI (esomeprazole 40 mg/day before breakfast) and mucosal protective drugs (a combination of hyaluronic acid, chondroitin sulfate and poloxamer 407, or a combination of hyaluronic acid, chondroitin sulfate and aluminum, before sleep); Group F: PPI (esomeprazole 40 mg/day before breakfast) and prokinetics (levosulpiride 25 mg or domperidone 10 mg before lunch and dinner). Symptoms were evaluated using the visual analogue scale (VAS) and global symptomatic score (GSS), as follows: heartburn: 0-3; retrosternal chest pain: 0-3; regurgitation: 0-3.
Results: All but 2 treatments (groups C and D) significantly improved VAS and GSS, with group E showing the most significant GSS improvement. Group C had the highest number of dropouts due to treatment failure and reported more side effects.
Conclusion: Using PPIs and mucosal protective drugs resulted in significant symptom alleviation. However, the administration of prokinetics caused higher dropouts due to treatment failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17219/acem/171001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Glutathione-responsive and mitochondria targeting enhanced photodynamic therapy and cascade-triggered carbon monoxide release for all-in-one tumor therapy.
J Colloid Interface Sci
September 2025
School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China; Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, Henan Normal University, Xinxiang, Henan 453007, China. Electronic address:
Carbon monoxide (CO) has demonstrated significant potential in tumor therapy. However, the uncontrolled release of CO and single-modality therapy often fail to achieve the desired therapeutic outcomes. To address the above deficiencies, mesoporous silica nanoparticles containing tetrasulfide bonds (TMSNs) were constructed as intelligent nanocarriers to co-deliver a mitochondria-targeting photosensitizer (Au-TPP) and a photodynamically activated CO-releasing molecule (FeCO), enabling the synergistic combination of photodynamic therapy (PDT) and CO therapy.
View Article and Find Full Text PDFNatural-Based Nanocomposite Ink Engineering for Seamless Multi-Material Integration in Extrusion-Based 3D Printing.
Adv Healthc Mater
September 2025
Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Aveiro, 3810-193, Portugal.
Multi-tissue regeneration remains a critical clinical challenge due to the lack of solutions that can replicate the hierarchical heterogeneity of such complex interfaces. While biofabrication approaches, such as extrusion-based, allow replicating robust, biomimetic, and layered designs, constructs are usually hindered by inadequate phase/layer integration, poor filler dispersion, and mismatched rheological and mechanical performances. This study introduces an ink engineering strategy as a solution for integrating natural-based nanocomposites in multi-tissue regenerative approaches.
View Article and Find Full Text PDFExploring topical atorvastatin hyalurosomal gel as an adjuvant for reducing systemic corticosteroid dosage: a randomized clinical trial in severe oral lichen planus patients.
Drug Deliv Transl Res
September 2025
Pharmaceutics and Drug Manufacturing Department, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, 11571, Egypt.
Oral lichen planus (OLP) is a chronic inflammatory disorder with limited topical treatment options and long-term corticosteroid dependency. This study investigates a novel atorvastatin-loaded hyalurosomal gel (ATV-Hyalugel) as a topical adjuvant to reduce systemic corticosteroid use in severe OLP. The objective of the study is to develop, optimize, characterize ATV-Hyalugel and evaluate its clinical efficacy in a randomized controlled clinical trial.
View Article and Find Full Text PDFHyaluronic acid and polyvinyl alcohol-based radioresponsive hydrogel for combined radioimmunotherapy of breast cancer bone metastasis.
Carbohydr Polym
November 2025
State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China. Electronic address:
Combining radiotherapy with immunotherapy holds promise for treating solid tumors and metastases, but challenges persist, including hypoxia-induced immunosuppression and immune-related adverse events from off-target toxicity. To address this, we engineered an in-situ formed hydrogel by crosslinking hyaluronic acid and polyvinyl alcohol with a reactive oxygen species (ROS)-responsive linker (3-aminophenylboronic acid). This hydrogel leverages radiotherapy-induced ROS within the tumor microenvironment to trigger localized release of nitric oxide (NO) and the toll-like receptor 7/8 (TLR7/8) agonist R848.
View Article and Find Full Text PDFAdvancements in hydrogels: A comprehensive review of natural, synthetic, and hybrid innovations for wound healing.
Int J Biol Macromol
September 2025
The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China. Electronic address:
Natural and synthetic hydrogels are beneficial for wound healing because of their biocompatibility, biodegradability, and capability to maintain a moist healing environment. Natural hydrogels, sourced from materials like hyaluronic acid (HA), chitosan, alginate, and collagen, replicate the extracellular matrix and play a vital role in cell migration, proliferation, and tissue regeneration. These materials promote wound healing by keeping a moist environment and offer inherent biological benefits, including anti-inflammatory, antioxidant, and antimicrobial properties.
View Article and Find Full Text PDF